Abstract

Patients with advanced cancer often show evidence of impaired immunological defences which could be made worse by most of the commonly used anti-cancer drugs. However some patients have intact immunological defences and in the case of some lymphomas this is reflected in a better prognosis. Recently drugs have been used in cancer in an attempt to stimulate the patient’s own defences against his disease.